Fuller & Thaler Asset Management Inc. lifted its stake in shares of Olin Co. (NYSE:OLN - Free Report) by 11.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,543,844 shares of the specialty chemicals company's stock after buying an additional 467,680 shares during the period. Fuller & Thaler Asset Management Inc. owned approximately 3.90% of Olin worth $153,582,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also made changes to their positions in OLN. Covestor Ltd lifted its position in Olin by 45.8% during the fourth quarter. Covestor Ltd now owns 1,334 shares of the specialty chemicals company's stock valued at $45,000 after purchasing an additional 419 shares during the period. Spire Wealth Management lifted its position in Olin by 246.8% during the fourth quarter. Spire Wealth Management now owns 1,616 shares of the specialty chemicals company's stock valued at $55,000 after purchasing an additional 1,150 shares during the period. CoreFirst Bank & Trust acquired a new position in Olin during the fourth quarter valued at $66,000. Jones Financial Companies Lllp lifted its position in Olin by 59.9% during the fourth quarter. Jones Financial Companies Lllp now owns 2,431 shares of the specialty chemicals company's stock valued at $82,000 after purchasing an additional 911 shares during the period. Finally, Blue Trust Inc. lifted its position in Olin by 34.3% during the fourth quarter. Blue Trust Inc. now owns 2,887 shares of the specialty chemicals company's stock valued at $98,000 after purchasing an additional 738 shares during the period. 88.67% of the stock is currently owned by institutional investors and hedge funds.
Olin Price Performance
NYSE OLN traded down $0.26 during trading hours on Monday, hitting $21.75. 306,555 shares of the company's stock traded hands, compared to its average volume of 1,892,264. Olin Co. has a 52-week low of $17.66 and a 52-week high of $57.10. The company has a market capitalization of $2.50 billion, a PE ratio of 24.17 and a beta of 1.50. The company has a debt-to-equity ratio of 1.32, a current ratio of 1.27 and a quick ratio of 0.77. The firm's 50-day moving average is $23.37 and its 200-day moving average is $32.36.
Olin (NYSE:OLN - Get Free Report) last announced its quarterly earnings data on Thursday, January 30th. The specialty chemicals company reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.10. Olin had a net margin of 1.66% and a return on equity of 5.10%. Equities analysts forecast that Olin Co. will post 1.38 EPS for the current fiscal year.
Olin Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Thursday, March 6th were paid a dividend of $0.20 per share. The ex-dividend date of this dividend was Thursday, March 6th. This represents a $0.80 annualized dividend and a yield of 3.68%. Olin's dividend payout ratio is presently 88.89%.
Wall Street Analysts Forecast Growth
A number of research analysts have weighed in on the stock. Piper Sandler decreased their price objective on shares of Olin from $33.00 to $26.00 and set a "neutral" rating for the company in a research report on Monday, April 7th. Truist Financial decreased their price objective on shares of Olin from $32.00 to $25.00 and set a "hold" rating for the company in a research report on Monday, April 14th. Mizuho set a $23.00 price objective on shares of Olin in a research report on Tuesday, April 15th. KeyCorp decreased their price objective on shares of Olin from $40.00 to $34.00 and set an "overweight" rating for the company in a research report on Monday, April 14th. Finally, Royal Bank of Canada downgraded shares of Olin from an "outperform" rating to a "sector perform" rating and decreased their price objective for the stock from $45.00 to $30.00 in a research report on Tuesday, February 4th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, Olin currently has a consensus rating of "Hold" and an average price target of $33.25.
Read Our Latest Analysis on Olin
Insider Activity at Olin
In other news, CEO Kenneth Todd Lane bought 7,250 shares of the firm's stock in a transaction on Tuesday, February 4th. The shares were bought at an average cost of $28.06 per share, for a total transaction of $203,435.00. Following the acquisition, the chief executive officer now directly owns 7,250 shares of the company's stock, valued at $203,435. This trade represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. 1.60% of the stock is owned by corporate insiders.
Olin Profile
(
Free Report)
Olin Corporation manufactures and distributes chemical products in the United States, Europe, Asia Pacific, Latin America, and Canada. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, and chlorinated organics intermediates and solvents.
Featured Stories

Before you consider Olin, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Olin wasn't on the list.
While Olin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.